Major Quest restructure sees up to 600 managers head for the chop
This article was originally published in Clinica
Quest Diagnostics is undergoing a major overhaul which will see three management layers pared off from the current business structure, resulting in the loss of 400 to 600 jobs by the end of 2013. The move, said the company, will enable it to "focus more on customers, speed up decision-making and accelerate cost reductions". While Quest will take a hit of about $15-20 million in charges from this management restructure, the company expects to gain about $65 million in annual savings.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.